Sv Health Investors, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Sv Health Investors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$7.7 - $37.13 $3.46 Million - $16.7 Million	-449,951 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$31.7 - $69.93 $2.92 Million - $6.45 Million	-92,192 Reduced 17.01%	449,951 $28 Million
Q3 2019 Nov 14, 2019	SELL	$19.95 - $38.85 $7.51 Million - $14.6 Million	-376,194 Reduced 40.96%	542,143 $18.4 Million
Q2 2019 Aug 14, 2019	SELL	$21.05 - $26.21 $6.73 Million - $8.38 Million	-319,861 Reduced 25.83%	918,337 $20.7 Million
Q1 2019 May 15, 2019	SELL	$20.65 - $29.55 $1.01 Million - $1.45 Million	-49,029 Reduced 3.81%	1,238,198 $28.7 Million
Q4 2018 Feb 14, 2019	SELL	$19.08 - $36.14 $8.19 Million - $15.5 Million	-429,076 Reduced 25.0%	1,287,227 $27 Million
Q3 2017 Nov 14, 2017	BUY	$17.65 - $18.99 $30.3 Million - $32.6 Million	1,716,303	1,716,303 $32.6 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Sv Health Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sv Health Investors, LLC with notifications on news.